# Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/proprotein-convertase-subtilisin-kexin-type-9-inhibitor-therapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gregory P. Hess,Pradeep Natarajan,Kamil F. Faridi,Anna Fievitz,Linda R. Valsdottir,Robert W. Yeh |
| Citations | 58 |
| DOI | 10.1161/circulationaha.117.028430 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.028430 |
| OpenAlex ID | https://openalex.org/W2766569988 |
| PMID | 29084735 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Gregory P. Hess](https://scholariq.org/researchers/gregory-p-hess/)

## Paper journal

- [Circulation](https://scholariq.org/journals/circulation/)

## Paper primary topic

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Paper topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.